Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What key factors are powering the surge in the vaccine adjuvants market right now?

The market size for vaccine adjuvants has seen significant growth in the past few years. The market, which is expected to rise from $1.89 billion in 2024 to $2.03 billion in 2025, boasts a compound annual growth rate (CAGR) of 7.6%. The growth during the historic period is due to several factors including the rise in vaccine development, increasing prevalence of infectious diseases, government support and vaccination campaigns, investments in research and development, as well as the global spread of vaccine distribution.

How fast Is the vaccine adjuvants market expected to grow, and what’s its future value?

In the upcoming years, a significant surge is anticipated in the vaccine adjuvants market, which is projected to reach “$2.89 billion by 2029, reflecting a compound annual growth rate (CAGR) of 9.2%. The expansion projected within this forecast period can be linked to the preparedness for pandemics, enhancing vaccine collections, worldwide vaccination aims, partnerships and joint efforts, as well as an emphasis on therapeutic vaccines. Key trends projected within this period encompass advancements in adjuvant technologies, a focus on amping up immunogenicity, combined adjuvants for improved efficacy, a need for safer and better-tolerated adjuvants, and bespoke vaccines and adjuvants.

Get your vaccine adjuvants market report here!

https://www.thebusinessresearchcompany.com/report/vaccine-adjuvants-global-market-report

What are the leading drivers of growth in the vaccine adjuvants market?

The increasing occurrence of infectious diseases is predicted to fuel the expansion of the vaccine adjuvants market in the future. These infectious diseases are caused by various agents such as viruses, bacteria, fungi, or parasites and are combated using vaccines for illnesses such as hepatitis B (HBV), hepatitis C (HCV), HIV, malaria, syphilis, and brucellosis. For example, the 2022 report by the World Health Organization (WHO) revealed that in 2021, around 10.6 million individuals worldwide contracted tuberculosis, 1.6 million succumbed to the disease, and another 1.5 million people were diagnosed with HIV in the same year, resulting in 650,000 fatalities. Hence, the escalating incidence of such infectious diseases is set to boost the vaccine adjuvants market.

What are the key segments defining the vaccine adjuvants market?

The vaccine adjuvants market covered in this report is segmented –

1) By Product Type: Adjuvant Emulsions, Pathogen Components, Particulate Adjuvants, Combination Adjuvants, Other Product Types

2) By Route of Application: Human Vaccine Adjuvants, Veterinary Vaccine Adjuvants

3) By Route of Administration: Oral, Intramuscular, Intranasal, Subcutaneous, Intradermal

4) By Disease: Cancer, Infectious Diseases, Other Diseases

Subsegments:

1) By Adjuvant Emulsions: Oil-In-Water Emulsions, Water-In-Oil Emulsions

2) By Pathogen Components: Bacterial Components, Viral Components

3) By Particulate Adjuvants: Liposomes, Nanoparticles, Microparticles

4) By Combination Adjuvants: Mixed Emulsions, Multiple Component Systems

5) By Other Product Types: Synthetic Adjuvants, Natural Adjuvants

Get your free sample now – explore exclusive market insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10121&type=smp

Who are the key players steering the development of the vaccine adjuvants market?

Major companies operating in the vaccine adjuvants market include GlaxoSmithKline Plc., Novavax Inc., SPI Pharma Inc., Agenus Inc., CSL Limited, InvivoGen Limited., Brenntag Biosector A/S, Adjuvatis, Merck KGaA, Croda International Plc, Seppic Inc, OZ Biosciences, Avanti Polar Lipids Inc, Astellas Pharma Inc, Virometix AG, MPV Technologies Limited, Adjuvance Technologies Inc., Novartis AG, Vaxine Pty Ltd, SBI Biotech Co. Ltd., Statens Serum Institute, GSK Vaccines, VaxLiant LLC, VaxForm LLC, Serum Institute of India, Dynavax Technologies Corporation, Vaxcyte Inc., VBI Vaccines Inc., Medicago Inc., Aphios Corporation

What emerging trends are influencing the growth of the vaccine adjuvants market?

Emerging trend in the vaccine adjuvants market is notably product innovation. Companies within this market are leveraging innovative solutions to consolidate their positions. For example, Evonik Industries, a chemical manufacturing firm based in Germany, unveiled PhytoSquene, a plant-sourced squalene extracted from amaranth oil in December 2022. This sustainable substitute for traditional shark-sourced squalene is purposed for use in vaccine adjuvants and various other pharmaceutical uses, and it augments vaccine efficiency through immune response intensification. The creation of PhytoSquene exemplifies the mounting emphasis on sustainability within the pharmaceutical industry.

Unlock exclusive market insights – purchase your research report now for a swift delivery!

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10121

Which regions are most influential in expanding the vaccine adjuvants market?

North America was the largest region in the vaccine adjuvants market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global vaccine adjuvants market report during the forecast period. The regions covered in the vaccine adjuvants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Browse Through More Similar Reports By The Business Research Company:

Emulsifiers Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/emulsifiers-global-market-report

Chemicals Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/chemicals-global-market-report

Ethylene Global Market Report 2023

https://www.thebusinessresearchcompany.com/report/ethylene-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: